Google Übersetzer
Argenx Se
About
685.00EUR+9.40 +1.39%
Closed • Updated at 17:16 GMT+00:00Market Cap$48.74B
P/E Ratio39.95
Volume73.8K
Beta1.01
RSI52.65
Gross Margin88.66%
Argenx Se — investor relations, events, news, and company updates on 6ix.
Latest News
May 8 2026
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
May 7 2026
argenx Reports First Quarter 2026 Financial Results and Provides Business Update
May 6 2026
argenx to Present at BofA Securities 2026 Health Care Conference
May 6 2026
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
Apr 30 2026
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
Recent Videos
Why Argenx Organizes Every Team Like A Startup
Apr 30, 2026
製薬会社・アルジェニクス社員 人事担当 ミキさんのストーリー
Apr 30, 2026
製薬会社・アルジェニクス社員 人事担当 ミキさんのストーリー
Apr 30, 2026
Leaders at All Levels: How Argenx Scaled to $4 Billion Without Bureaucracy
Apr 29, 2026